Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sevoflurane and remifentanil interaction during general anesthesia
ACTRN12606000522516Phase 3Not yet recruiting
- Sponsor
- Dr Doug Campbell
- Start
- Jul 2006
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of sevoflurane and remifentanil, sponsored by Dr Doug Campbell. Primary endpoints: Bispectral Index (BIS) and Observer Assessment of Sleep and Sedation (OASS). Planned start Jul 2006; status: not yet recruiting.
02
Drugs
sevofluraneremifentanil
Beyond the preview
Go deeper on ACTRN12606000522516.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12606000522516.